Latest News- AI In Oncology Market: Software solutions is expected to lead the Component segment during 2025-2029

The AI In Oncology Market is being driven by Increasing volume and complexity of oncological data

The AI In Oncology Market is expected to grow at a CAGR of 27.8% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 7540.1 million. The global AI for oncology market is witnessing a significant transition from mono-modal AI systems, which analyze individual data types in isolation, to advanced multimodal AI platforms. This evolution signifies a growing recognition that cancer is a complex and heterogeneous disease, necessitating a more comprehensive understanding. Multimodal AI systems integrate and analyze diverse datasets, including medical imaging, genomics, and pathology, in unison. By uncovering intricate relationships and predictive patterns that remain undetected when data is siloed, multimodal AI platforms offer a more holistic and accurate approach to cancer diagnosis and treatment. 

Get more information on AI In Oncology Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Component
  • Software solutions
  • Services
• Type
  • Breast cancer
  • Lung cancer
  • Kidney cancer
  • Others
• Application
  • Diagnosis
  • Drug discovery and development
  • Treatment planning
  • Prognosis prediction
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
    • Italy
  • APAC
    • China
    • India
    • Japan
  • South America
    • Brazil
  • Middle East and Africa

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Increasing volume and complexity of oncological data
• Growing demand for personalized medicine and precision oncology
• Accelerating technological advancements in AI and computational infrastructure

However, the market also witnesses some limitations, which are as follows:

• Data scarcity, quality, and accessibility
• Regulatory hurdles and reimbursement uncertainty
• Clinical integration and clinician trust

Benefits of Buying Global AI In Oncology Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in AI In Oncology Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

In the AI market for oncology, advanced technologies are being utilized to revolutionize cancer diagnosis, treatment, and research. Multi-omics data integration and tumor microenvironment analysis enable disease modeling, biomarker discovery, and drug target identification. AI applications optimize clinical workflows, enhance drug development, and facilitate clinical trial matching. Data visualization, knowledge graphs, and real-world evidence support clinical decision-making. Ethics, bias mitigation, and regulatory compliance ensure trust and accuracy. Digital pathology, remote patient monitoring, and patient engagement improve accessibility and outcomes. AI ethics, model explainability, and algorithm validation ensure transparency and reliability. Cancer screening and disease progression monitoring are essential applications of AI in oncology.

Market Research Overview

In the dynamic landscape of the global IT software industry, the application software segment holds significant importance, particularly in the burgeoning field of oncology. Companies specializing in this sector develop radiomics features software, leveraging advanced imaging techniques to extract valuable data from medical images, enabling improved tumor diagnosis and treatment planning. Additionally, the advent of liquid biopsy and genomic profiling technologies has fueled the demand for software solutions capable of analyzing vast amounts of genomic data, thereby enhancing the precision and effectiveness of cancer treatment. The global application software market for oncology is expected to witness robust growth due to these technological advancements and the increasing prevalence of cancer worldwide.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/